CIK 0001001316
- Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363898269
- Phone
- +1 212-554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $274,800
- in 1 filing
Net −$274,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | Hoberman Kenneth Director | Grant or award · Stock Tracking Unit | +8,325 | 8,325 | ||
| 2025-06-12 | Hoberman Kenneth Director | Grant or award | +14,718 | 279,653 | ||
| 2024-06-19 | Hoberman Kenneth Director | Grant or award | +22,250 | 264,935 | ||
| 2023-09-28 | Hoberman Kenneth Director | Grant or award | +20,000 | 242,685 | ||
| 2022-07-20 | Hoberman Kenneth Director | Grant or award | +43,732 | 222,685 | ||
| 2021-06-18 | Hoberman Kenneth Director | Grant or award | +20,000 | 178,953 | ||
| 2020-06-22 | Hoberman Kenneth Director | Grant or award | +15,000 | 158,953 | ||
| 2019-09-17 | Hoberman Kenneth Director | Grant or award | +27,048 | 143,953 | ||
| 2018-06-26 | Hoberman Kenneth Director | Grant or award | +15,000 | 116,905 | ||
| 2017-06-16 | Hoberman Kenneth Director | Grant or award | +15,000 | 101,905 | ||
| 2016-07-06 | Hoberman Kenneth Director | Grant or award | +12,459 | 86,905 | ||
| 2015-06-04 | Hoberman Kenneth Director | Grant or award | +4,667 | 74,446 |
Page 1 of 1 · 12 trades